Authorities in Uzbekistan have expedited the process of fully compensating families who suffered material and moral damages following the consumption of the controversial 'Doc-1 Max' and 'Ambronol' pharmaceutical products. According to enforcement documents issued by the Tashkent City Criminal Court, the Compulsory Enforcement Bureau was originally tasked with recovering a total of 82 billion sums in compensation for the benefit of 90 victims.

However, the liquidation process involving the seized property of the convicted individuals reportedly dragged on past initial deadlines, resulting in the disbursement of only 16.8 billion sums—roughly 20 percent of the mandated total—prior to recent interventions. The remaining balance had remained unpaid for a prolonged period, prompting leadership to issue direct instructions to accelerate the restitution process without further delay.

In response to these directives, an allocation of 65.2 billion sums was swiftly drawn from the state budget to cover the shortfall. To date, a total of 80 billion sums has been successfully disbursed to 88 victims, which includes 72.2 billion sums distributed among the families of the 72 children who tragically lost their lives, and 7.8 billion sums allocated to the families of 16 children who received medical treatment. The remaining 2 billion sums for the final two families will be transferred as soon as technical banking card issues are fully resolved.

Officials noted that the 65.2 billion sums provided from the state budget will eventually be reimbursed to the republican treasury through the proceeds generated from the ongoing sale of the culprits' confiscated assets. Meanwhile, representatives from the Ministry of Health and relevant government agencies, alongside leading national medical specialists, continue to monitor the well-being of the affected families, providing them with supplementary medical and psychological support.

Source: kun.uz